Novel benzo-fused heterocycles as endothelin antagonisits

Details for Australian Patent Application No. 2002328999 (hide)

International Classifications

Event Publications

30 January 2003 Complete Application Filed

Priority application(s): PCT/EP01/09235 09.08.01 EP

19 June 2003 Application Open to Public Inspection

Published as AU-B-2002328999

15 May 2008 Application Accepted

Published as AU-B-2002328999

5 June 2008 Corrigenda

Applications Accepted - Name Index Under the Name Actelion Pharmaceuticals Ltd., Application No. 2002328999, under INID (54), correct the title of the invention to Novel benzo-fused heterocycles as endothelin antagonists

11 September 2008 Standard Patent Sealed

24 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.